Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device

NCT06807502 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer, Metastatic
Breast Cancer Invasive
Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Interventions

DEVICE: The DM/DIV ScreenCell is the experimental product studied during this research

Sponsor

ScreenCell

Collaborators

[object Object]